Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)
NCT00929253 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170
Last updated 2022-05-27
Summary
This study is designed to examine the effects of combined buprenorphine and voucher incentives to promote abstinence from illicit opiate use, along with or without computer-delivered therapy, during treatment of opioid dependence.
Conditions
- Opiate Addiction
Interventions
- DRUG
-
Suboxone
Dosage Form: Oral Tablet; Dosage 6, 12, or 18 mg; Frequency; Daily; Duration 12 weeks
- BEHAVIORAL
-
CRA
Computer-delivered Community Reinforcement Approach
- BEHAVIORAL
-
Therapy
Therapist-delivered therapy
- BEHAVIORAL
-
CM
Contingency management (vouchers) for providing a drug negative urine sample.
Sponsors & Collaborators
-
Virginia Polytechnic Institute and State University
lead OTHER
Principal Investigators
-
Warren K Bickel, Ph.D. · Virginia Polytechnic Institute and State University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
- Primary Completion
- 2010-04-30
- Completion
- 2010-04-30
Countries
- United States
Study Locations
More Related Trials
-
Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence
NCT00555425 ·Status: COMPLETED ·Phase: PHASE4
-
CBT4CBT for Office Based Buprenorphine
NCT03580902 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone
NCT01637922 ·Status: COMPLETED ·Phase: PHASE1
-
CBT4CBT-Buprenorphine + Recovery Coach for Office-based Buprenorphine
NCT04824404 ·Status: COMPLETED ·Phase: NA
-
Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
NCT00249574 ·Status: COMPLETED ·Phase: NA
-
A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment
NCT05189223 ·Status: RECRUITING ·Phase: NA
-
Buprenorphine Maintenance for Opioid Addicts - 1
NCT00000202 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
NCT00367302 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Remote Observed Dosing to Increase Suboxone Compliance
NCT01779973 ·Status: COMPLETED ·Phase: NA
-
Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
NCT01096550 ·Status: COMPLETED ·Phase: NA
-
Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.
NCT03212794 ·Status: COMPLETED ·Phase: NA
-
Clinical Rescue Protocol - 2
NCT00000206 ·Status: COMPLETED ·Phase: PHASE2
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
NCT06732596 ·Status: RECRUITING ·Phase: NA
-
Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction
NCT00609089 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
NCT03616236 ·Status: SUSPENDED ·Phase: PHASE3
-
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
NCT00000211 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Adherence App for Buprenorphine Treatment (TAAB) Study
NCT03779997 ·Status: COMPLETED ·Phase: NA
-
Remote Observed Dosing of Suboxone to Improve Clinical Practice
NCT03769025 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1
NCT00023283 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine for Prisoners
NCT00574067 ·Status: COMPLETED ·Phase: PHASE3
-
Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
NCT07342504 ·Status: RECRUITING ·Phase: NA
-
Together in Recovery With Veterans Through Employment
NCT05388812 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3
NCT02902835 ·Status: TERMINATED ·Phase: NA
-
Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation
NCT03420313 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
NCT00000210 ·Status: COMPLETED ·Phase: PHASE2